Enable your JavaScript to use Numstock


Numstock » ADMS

ADMS Stock Analysis

The latest metrics for Adamas Pharmaceuticals, Inc

Value

Metric Target Value
Price / Earnings Ratio < 12.0 -1.29
Price / Book Value Ratio < 1.5 7.72
Price / Sales Ratio < 2.0 2.92
PEG Ratio < 1.0 -0.06
EV / EBITDA Ratio < 8.0 -1.44
Price / FCF Ratio Last Year < 15.0 -1.27
Price / FCF Ratio Last Quarter < 15.0 -7.5
Price / TBV Ratio Last Year < 0.7 1.64
Price / TBV Ratio Last Quarter < 0.7 7.75
Price / NCAV Ratio Last Year < 0.7 1.77
Price / NCAV Ratio Last Quarter < 0.7 23.22

Efficiency

Metric Target Value
ROE Last Year > 25.0% -167.9
ROE Last Quarter > 25.0% -88.32
ROA Last Year > 15.0% -55.79
ROA Last Quarter > 15.0% -15.29
ROTA Last Year > 20.0% -63.75
ROTA Last Quarter > 20.0% -11.32
ROIC Last Year > 20.0% -60.28
ROIC Last Quarter > 20.0% -22.45
ROCE Last Year > 20.0% -54.63
ROCE Last Quarter > 20.0% -13.07
Inventory Turnover Last Year > 4.0 0.12
Inventory Turnover Last Quarter > 4.0 0.18
Pre-tax Margin Last Year > 20.0% -487.1
Pre-tax Margin Last Quarter > 20.0% -250.6
Accounts Payable Turnover Last Year > 3.0 0.1
Accounts Payable Turnover Last Quarter > 3.0 0.14
Accounts Receivable Turnover Last Year > 5.0 0.1
Accounts Receivable Turnover Last Quarter > 5.0 0.15

Health

Metric Target Value
Current Ratio Last Year > 1.5 9.41
Current Ratio Last Quarter > 1.5 6.89
Quick Ratio Last Year > 1.5 9.2
Quick Ratio Last Quarter > 1.5 6.68
Flow Ratio Last Year < 1.25 7.6
Flow Ratio Last Quarter < 1.25 4.23
Debt / Equity Ratio Last Year < 0.5 1.31
Debt / Equity Ratio Last Quarter < 0.5 6.28
Debt / EBITDA Ratio Last Year < 4.0 -1.16
Debt / EBITDA Ratio Last Quarter < 4.0 -1.23
Debt / NCAV Ratio Last Year < 2.0 1.41
Debt / NCAV Ratio Last Quarter < 2.0 18.81
Long-term Debt / Working Capital Ratio Last Year < 2.0 0.58
Long-term Debt / Working Capital Ratio Last Quarter < 2.0 0.87
Interest Coverage Ratio Ratio Last Year > 8.0 6.02
Interest Coverage Ratio Last Quarter > 8.0 5.27
FCF / Sales Ratio Last Year > 8.0% -309.2
FCF / Sales Ratio Last Quarter > 8.0% -133.9

Growth

Metric Target Value
Earnings Yield > 12% -77.73
Ebit Yield Last Year > 12% -47.79
Ebit Yield Last Quarter > 12% -8.47
FCF Yield Last Year > 10% -69.09
FCF Yield Last Quarter > 10% -12.24
Forward P/E to Trailing P/E Ratio > 1.1 0.0
Operating Cash Flow / EPS Ratio Last Year > 1.2 0.91
Operating Cash Flow / EPS Ratio Last Quarter > 1.2 0.16

Dividends

Metric Target Value
Dividend Yield > 2.0% 0.0
FCF / Dividends Paid Ratio Last Year > 2.5 0.0
FCF / Dividends Paid Ratio Last Quarter > 2.5 0.0
EPS / Dividends Paid Last Year > 2.5 0.0
EPS / Dividends Paid Last Quarter > 2.5 0.0
Payout Ratio < 40.0% 0.0

Ratings

Metric Target Value
Altman Z-score Last Year ≥ 3.5 -2.09
Altman Z-score Last Quarter ≥ 3.5 -2.13